EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte Studie

Increased incidence of adverse events in diabetes mellitus patients with combined multiple vulnerable plaque features: new insights from the COMBINE OCT-FFR trial

David Del Val iD, Balazs Berta, Tomasz Roleder, Krzysztof Malinowski, Teresa Bastante iD, Renicus S Hermanides iD, Wojciech Wojakowski iD, Enrico Fabris iD, Javier Cuesta, Giuseppe De Luca, Fernando Rivero iD, Fernando Alfonso iD und 1 weitere

European Heart Journal - Cardiovascular Imaging · 2024

DOI: 10.1093/ehjci/jeae210 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Heart Journal - Cardiovascular Imaging, 2024. Verfasst von David Del Val und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Hospital Universitario de La Princesa, Madrid, Spain. Hauptthemen laut MEDLINE: Tomography, Optical Coherence, Plaque, Atherosclerotic, Coronary Artery Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Isala Hartcentrum, St Jude Medical, Abbott Vascular.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate the individual as well as combined impact of optical coherence tomography-detected vulnerability features (OCT-VFs) in the prediction of major adverse cardiovascular events (MACEs) in non-ischaemic lesions in patients with diabetes mellitus (DM). Methods and results The COMBINE OCT-FFR (NCT02989740) was a prospective, double-blind, international, natural-history study that included patients with DM having ≥1 lesions with a fractional flow reserve > 0.80, undergoing systematic OCT assessment. Pre-specified OCT-VFs included thin-cap fibroatheroma (TCFA), reduced minimal lumen area (r-MLA), high plaque burden (h-PB), and complicated plaque (CP). The primary endpoint (MACE) was a composite of cardiac mortality, target vessel myocardial infarction, clinically driven target lesion revascularization, or hospitalization for unstable angina up to 5 years, analysed according to the presence of these OCT-VFs, both individually and in combination. TCFA, r-MLA, h-PB, and CP were identified in 98 (25.1%), 159 (40.8%), 56 (14.4%), and 116 (29.8%) patients, respectively. The primary endpoint rate increased progressively from 6.9% to 50.0% (HR = 10.10; 95% CI, 3.37–30.25, P < 0.001) in patients without OCT-VFs compared with those with concomitant h-PB, r-MLA, CP, and TCFA. Importantly, while TCFA, h-PB, r-MLA, and CP were individually associated with the primary endpoint, the presence of two or more OCT-VFs significantly increased the likelihood of adverse events at 5 years.

Conclusion

In patients with DM and non-ischaemic lesions, TCFA, h-PB, r-MLA, and CP were predictors of adverse events. However, the presence of two or more OCT-VFs significantly increased the likelihood of MACE at 5 years. Further studies are warranted to confirm these findings and their potential clinical implications in a randomized fashion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tomography, Optical CoherencePlaque, AtheroscleroticCoronary Artery DiseaseHumansMaleFemaleProspective StudiesDouble-Blind MethodMiddle AgedAgedFractional Flow Reserve, MyocardialIncidenceRisk Assessment

Stichwörter der Autor:innen

coronary artery diseasediabetes mellitusoptical coherence tomographyvulnerable plaque

Autor:innen und Institutionen

  • Cardiology Department, Hospital Universitario de La Princesa, Madrid, Spain.
  • CIBERCV, Instituto de Investigación Sanitaria, IIS-IP, Hospital Universitario de La Princesa, Madrid, Spain.
  • Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Isala Hartcentrum, Zwolle, The Netherlands.
  • Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland.
  • Department of Cardiology, Wroclaw Medical University, Wroclaw, Poland.

ORCID-Profile: David Del Val, Teresa Bastante, Renicus S Hermanides, Wojciech Wojakowski, Enrico Fabris, Fernando Rivero, Fernando Alfonso, Elvin Kedhi

Förderung

  • Isala Hartcentrum
  • St Jude Medical
  • Abbott Vascular

Zitieren

APA

Del Val, D., Berta, B., Roleder, T., Malinowski, K., Bastante, T., Hermanides, R. S., Wojakowski, W., Fabris, E., Cuesta, J., De Luca, G., Rivero, F., Alfonso, F., & Kedhi, E. (2024). Increased incidence of adverse events in diabetes mellitus patients with combined multiple vulnerable plaque features: new insights from the COMBINE OCT-FFR trial. European Heart Journal - Cardiovascular Imaging. https://doi.org/10.1093/ehjci/jeae210

Vancouver

Del Val D, Berta B, Roleder T, Malinowski K, Bastante T, Hermanides RS, et al. Increased incidence of adverse events in diabetes mellitus patients with combined multiple vulnerable plaque features: new insights from the COMBINE OCT-FFR trial. European Heart Journal - Cardiovascular Imaging. 2024. doi:10.1093/ehjci/jeae210

BibTeX
@article{DelVal2024,
  author = {Del Val, David and Berta, Balazs and Roleder, Tomasz and Malinowski, Krzysztof and Bastante, Teresa and Hermanides, Renicus S and Wojakowski, Wojciech and Fabris, Enrico and Cuesta, Javier and De Luca, Giuseppe and Rivero, Fernando and Alfonso, Fernando and Kedhi, Elvin},
  title = {Increased incidence of adverse events in diabetes mellitus patients with combined multiple vulnerable plaque features: new insights from the COMBINE OCT-FFR trial},
  journal = {European Heart Journal - Cardiovascular Imaging},
  year = {2024},
  doi = {10.1093/ehjci/jeae210}
}
Kostenlos starten →